---
title: Rentschler Biopharma SE vs Xcellon Biologics
slug_a: rentschler-biopharma
slug_b: xcellon
site: cdmo
review_signal_gate: closed
canonical_path: /compare/rentschler-biopharma/xcellon
---

# Rentschler Biopharma SE vs Xcellon Biologics

Side-by-side profile data from each company listing on this directory.

## Rentschler Biopharma SE

- Profile: [/companies/rentschler-biopharma](/companies/rentschler-biopharma)

Rentschler Biopharma SE — Rentschler Biopharma is a family-owned CDMO offering bioprocess development and manufacturing of biopharmaceuticals, with about 50 years of experience. It operates sites in Laupheim, Germany and Milford, Massachusetts, USA.

Services: 8. Modalities: 1. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Regulatory Affairs
- Analytical Method Development & Validation
- Biologics Development & Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- Formulation Development
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Biologics (Other)

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Data not yet provided.

## Xcellon Biologics

- Profile: [/companies/xcellon](/companies/xcellon)

Xcellon Biologics — Maryland-based CDMO for complex biologics, including antibody-drug conjugates, bispecific antibodies, and T-cell engagers. Services span bioconjugation, bioprocess and analytical/formulation development, CGMP manufacturing, and in vivo pharmacology.

Services: 10. Modalities: 3. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (10).

### Services

- Discovery Research
- Protein Engineering
- Preclinical In Vivo Studies
- Bioanalysis
- Analytical Method Development & Validation
- Biologics Development & Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- Bioconjugation Services
- Process Development
- Formulation Development

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Data not yet provided.